» Articles » PMID: 14580334

Activin Receptor-like Kinase (ALK)1 is an Antagonistic Mediator of Lateral TGFbeta/ALK5 Signaling

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2003 Oct 29
PMID 14580334
Citations 310
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-beta (TGFbeta) regulates the activation state of the endothelium via two opposing type I receptor/Smad pathways. Activin receptor-like kinase-1 (ALK1) induces Smad1/5 phosphorylation, leading to an increase in endothelial cell proliferation and migration, while ALK5 promotes Smad2/3 activation and inhibits both processes. Here, we report that ALK5 is important for TGFbeta/ALK1 signaling; endothelial cells lacking ALK5 are deficient in TGFbeta/ALK1-induced responses. More specifically, we show that ALK5 mediates a TGFbeta-dependent recruitment of ALK1 into a TGFbeta receptor complex and that the ALK5 kinase activity is required for optimal ALK1 activation. TGFbeta type II receptor is also required for ALK1 activation by TGFbeta. Interestingly, ALK1 not only induces a biological response opposite to that of ALK5 but also directly antagonizes ALK5/Smad signaling.

Citing Articles

Modulation of TGF-β signaling new approaches toward kidney disease and fibrosis therapy.

Hong Q, Kim H, Cai G, Chen X, He J, Lee K Int J Biol Sci. 2025; 21(4):1649-1665.

PMID: 39990662 PMC: 11844295. DOI: 10.7150/ijbs.101548.


TGF-β1 Induces Mucosal Mast Cell Genes and is Negatively Regulated by the IL-3/ERK1/2 Axis.

Meurer S, Bronneberg G, Penners C, Kauffmann M, Braunschweig T, Liedtke C Cell Commun Signal. 2025; 23(1):76.

PMID: 39934802 PMC: 11817834. DOI: 10.1186/s12964-025-02048-8.


Unveiling the signal valve specifically tuning the TGF-β1 suppression of osteogenesis: mediation through a SMAD1-SMAD2 complex.

Wang Y, Luo C Cell Commun Signal. 2025; 23(1):38.

PMID: 39844165 PMC: 11752969. DOI: 10.1186/s12964-025-02051-z.


Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.

Qian C, Dong G, Yang C, Zheng W, Zhong C, Shen Q Cell Commun Signal. 2025; 23(1):16.

PMID: 39789529 PMC: 11720945. DOI: 10.1186/s12964-025-02028-y.


Hereditary haemorrhagic telangiectasia.

Hermann R, Shovlin C, Kasthuri R, Serra M, Eker O, Bailly S Nat Rev Dis Primers. 2025; 11(1):1.

PMID: 39788978 DOI: 10.1038/s41572-024-00585-z.